Calcium Intake and Risk of Colorectal Cancer According to Expression Status of Calcium-Sensing Receptor (CASR)
Wanshui Yang,Li Liu,Yohei Masugi,Zhi Rong Qian,Reiko Nishihara,NaNa Keum,Kana Wu,Stephanie Smith-Warner,Yanan Ma,Jonathan A. Nowak,Fatemeh Momen-Heravi,Libin Zhang,Michaela Bowden,Teppei Morikawa,Annacarolina da Silva,Molin Wang,Andrew T. Chan,Charles S. Fuchs,Jeffrey A. Meyerhardt,Kimmie Ng,Edward Giovannucci,Shuji Ogino,Xuehong Zhang
DOI: https://doi.org/10.1136/gutjnl-2017-314163
IF: 24.5
2017-01-01
Gut
Abstract:OBJECTIVE:Although evidence suggests an inverse association between calcium intake and the risk of colorectal cancer, the mechanisms remain unclear. The calcium-sensing receptor (CASR) is expressed abundantly in normal colonic epithelium and may influence carcinogenesis. We hypothesized that calcium intake might be associated with lower risk of CASR-positive, but not CASR-negative, colorectal cancer.DESIGN:We assessed tumour CASR protein expression using immunohistochemistry in 779 incident colon and rectal cancer cases that developed among 136 249 individuals in the Nurses' Health Study and Health Professionals Follow-Up Study. Duplication method Cox proportional hazards regression analysis was used to assess associations of calcium intake with incidence of colorectal adenocarcinoma subtypes by CASR status.RESULTS:Total calcium intake was inversely associated with the risk of developing colorectal cancer (ptrend=0.01, comparing ≥1200 vs <600 mg/day: multivariable HR=0.75, 95% CI 0.60 to 0.95). For the same comparison, higher total calcium intake was associated with a lower risk of CASR-positive tumours (ptrend=0.003, multivariable HR=0.67, 95% CI 0.51 to 0.86) but not with CASR-negative tumours (ptrend=0.67, multivariable HR=1.15, 95% CI 0.75 to 1.78; pheterogeneity=0.06 between the CASR subtypes). The stronger inverse associations of calcium intake with CASR-positive but not CASR-negative tumours generally appeared consistent regardless of sex, tumour location and source of calcium.CONCLUSIONS:Our molecular pathological epidemiology data suggest a causal relationship between higher calcium intake and lower colorectal cancer risk, and a potential role of CASR in mediating antineoplastic effect of calcium.